Phase 1 study of single, escalating subcutaneous doses of LY 2189265 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 May 2011
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Eli Lilly
- 05 Nov 2010 New trial record.